|
Mesothelioma Article Archives 2005
Despite Poor Prognosis, New Treatment Options for Mesothelioma May Extend Life and Decrease Symptoms: Presented at ONS
November 15, 2005
Tomudex® Plus Platinol® Improves Survival of Patients with Malignant Pleural Mesothelioma
Octobert 3, 2005
ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
August 25, 2005
Thoracic Cancer Patients Find New Reasons for Hope with Alimta®
July 5, 2005
Fujirebio Diagnostics Submits Application to FDA For Approval of MESOMARK™, the First Blood Test for Mesothelioma
June 28, 2005
| MIRG.org 1-888-802-6376 e-mail |  |
|
|
•
•
•
•
•
|
Mesothelioma Information
Resource Group, MIRG.org, tries to assist individuals and families in learning about mesothelioma and other asbestos related injuries. It is the aim of MIRG.org to provide an account of the disease mesothelioma, its causes, various treatment options and potential legal impact. To find out more about Mesothelioma and other asbestos related diseases, new medical advances, and clinical trials now available please use the links provided.
The information on this website is presented by the Mesothelioma Information Resource Group and is for informational purposes only.
No particular course of treatment is suggested. All persons are advised to consult with a medical doctor concerning treatment of
mesothelioma or any illness. Also, nothing on this website is intended to constitute legal advice by a lawyer or attorney. Note disclaimer.
|
